Acetaminophen and myocardial infarction in dogs
Open Access
- 1 November 2004
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 287 (5) , H1913-H1920
- https://doi.org/10.1152/ajpheart.00565.2004
Abstract
The hypothesis that acetaminophen can reduce necrosis during myocardial infarction was tested in male dogs. Two groups were studied: vehicle- ( n = 10) and acetaminophen-treated ( n = 10) dogs. All dogs were obtained from the same vendor, and there were no significant differences in their ages (18 ± 2 mo), weights (24 ± 1 kg), or housing conditions. Selected physiological data, e.g., coronary blood flow, nonspecific collateral flow, epicardial temperature, heart rate, systemic mean arterial pressure, left ventricular developed pressure, the maximal first derivative of left ventricular developed pressure, blood gases, and pH, were collected at baseline and during regional myocardial ischemia and reperfusion. There were no significant differences in coronary blood flow, nonspecific collateral flow, epicardial temperature, heart rate, systemic mean arterial pressure, or blood gases and pH between the two groups at any of the three time intervals, even though there was a trend toward improved function in the presence of acetaminophen. Infarct size, the main objective of the investigation, was markedly and significantly reduced by acetaminophen. For example, when expressed as a percentage of ventricular wet weight, infarct size was 8 ± 1 versus 3 ± 1%( P < 0.05) in vehicle- and acetaminophen-treated hearts, respectively. When infarct size was expressed as percentage of the area at risk, it was 35 ± 3 versus 13 ± 2% ( P < 0.05) in vehicle- and acetaminophen-treated groups, respectively. When area at risk was expressed as percentage of total ventricular mass, there were no differences in the two groups. Results reveal that the recently reported cardioprotective properties of acetaminophen in vitro can now be extended to the in vivo arena. They suggest that it is necessary to add acetaminophen to the growing list of pharmaceuticals that possess cardioprotective efficacy in mammals.Keywords
This publication has 40 references indexed in Scilit:
- Acetaminophen (Paracetamol) and Injury in the Cardiovascular SystemVascular Disease Prevention, 2004
- Effect of acetaminophen on the myeloperoxidase–hydrogen peroxide–nitrite mediated oxidation of LDLBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2002
- Infarct Size Limitation by a New Na-H Exchange Inhibitor, Hoe 642: Difference From Preconditioning in the Role of Protein Kinase CJournal of the American College of Cardiology, 1997
- Short-term low dose intracoronary diltiazem administered at the onset of reperfusion reduces myocardial infarct sizeInternational Journal of Cardiology, 1997
- Protective Effect of Acetaminophen against Acute Gastric Mucosal Lesions Induced by Ischemia-Reperf usion in the RatPharmacology, 1997
- The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusionCardiovascular Research, 1996
- Infarct Size Reduction with Coronary Venous Retroinfusion of Diltiazem in the Acute Occlusion/Reperfusion Porcine Heart ModelJournal of Cardiovascular Pharmacology, 1996
- The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusionCardiovascular Research, 1993
- The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injuryAmerican Heart Journal, 1992
- Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusionCritical Care Medicine, 1991